Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02228564 · ClinicalTrials.gov registry record · NA
BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
A NA study of Peripheral Artery Disease and Peripheral Vascular Disease, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 155
- Enrollment target
- 20
- Study locations
NCT02228564 is a NA study of Peripheral Artery Disease and Peripheral Vascular Disease that has completed, run by C. R. Bard. The registered enrollment target is 155 participants, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (25% higher). The trial reports 20 study locations across 10 states.
The verdict
NCT02228564, a NA study of Peripheral Artery Disease and Peripheral Vascular Disease, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 155 participants
- Enrollment target
- 20
- Study locations
Study Summary
Collect confirmatory evidence of the safety and effectiveness of the Balloon LIFESTREAM™ Stent Graft for the treatment of stenoses and occlusion in the iliac arteries.
Conditions Studied
Interventions
- PROCEDURE Percutaneous transluminal angioplasty (PTA)
- DEVICE LIFESTREAM™ covered stent
Study Locations (20)
Other
- Universitäts-Herzzentrum Freiburg-Bad Krozingen GmbH - Bad Krozingen
- Ev.Krankenhaus Königin Elisabeth - Berlin
- Praxis fur Interventionelle Angiologie - Kaiserslautern
- Universitaetsklinikum Leipzig - Leipzig
- Bonifatius Hospital - Lingen
- Auckland Hospital - Auckland
Florida
- Florida Research Network - Gainesville
- Baptist Medical Center - Jacksonville
- Lakeland Regional Medical Center - Lakeland
- Mount Sinai Medical Center - Miami
California
- Vascular and Interventional Specialists of Orange County - Orange
- UC Davis Cardiovascular Medicine - Sacramento
North Carolina
- CaroMont Regional Medical Center - Gastonia
- North Carolina Heart and Vascular - Raleigh
Arkansas
- Arkansas Heart Hospital - Little Rock
Massachusetts
- University of Massachusetts Worcester - Worcester
Missouri
- Kansas City Vascular Foundation - Kansas City
Pennsylvania
- Donald Guthrie Foundation - Sayre
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 155 participants |
| Start Date | 2014-09 |
| Est. Completion | 2018-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02228564
The ClinicalTrials.gov registry entry for NCT02228564 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 124-participant average among 50 other Peripheral Artery Disease trials with a reported enrollment target (25% higher). The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Peripheral Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Percutaneous transluminal angioplasty (PTA) is the first listed.
NCT02228564 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Other, Florida, California.
Frequently Asked Questions
What is clinical trial NCT02228564 about?
NCT02228564 is a clinical study titled "BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease". Collect confirmatory evidence of the safety and effectiveness of the Balloon LIFESTREAM™ Stent Graft for the treatment of stenoses and occlusion in the iliac arteries.
What is the current status of trial NCT02228564?
This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2014-09. Estimated completion is 2018-12.
What conditions does trial NCT02228564 study?
This clinical trial studies the following conditions: Peripheral Artery Disease, Peripheral Vascular Disease, Arterial Occlusive Disease.
What interventions are being tested in trial NCT02228564?
The interventions under investigation include: Percutaneous transluminal angioplasty (PTA) (PROCEDURE), LIFESTREAM™ covered stent (DEVICE).
Who is sponsoring clinical trial NCT02228564?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02228564 being conducted?
This trial has 20 study locations across Arkansas, California, Florida, Massachusetts, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peripheral Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease
RECRUITING · NA
-
BEETroot Juice to Reverse Functional Impairment in PAD
RECRUITING · NA
-
Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease
RECRUITING · NA
-
The THOR IDE Study
RECRUITING · NA
-
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
RECRUITING · NA
-
Leg Heat Therapy in Peripheral Artery Disease
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.